Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Deliver on the promises of the past and create smart solutions for the future.
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Emily Vandermause is a senior consulting actuary with the Milwaukee office of Milliman. She joined the firm in July 2009.
Emily has served many types of clients in her time with Milliman’s Healthcare Practice. She has assisted in performing actuarial work for Medicare Advantage organizations, employers, insurance companies, brokers, and numerous other healthcare clients. Through her experience she has gained insight into a variety of types of health care coverage, most recently focusing on the Medicare and Medicaid markets.
She has been involved in the development of Medicare Advantage bids since she began at Milliman. She has assisted large organizations in submitting bids for numerous plan offerings with extensive membership, including plans that focus on various special needs populations.
Her Medicare Advantage experience includes the following:
Emily’s Medicaid experience focuses primarily on developing managed care capitation rates for the acute care program in the state of Wisconsin. She also assists with developing and reviewing financial reporting templates that each of the individual managed care organizations submit to the state to help with encounter data validation.
Emily has also helped with the estimation of reserves and liabilities, premium rate development, retiree drug subsidy attestations, and various other actuarial projections and analyses.
In addition, Emily has been a key contributor to the development and ongoing maintenance of CORAL, a Milliman benefit and cost relativity comparison tool. The web-based tool allows employers, insurance companies, and brokers to evaluate the impact of changing medical and prescription drug plan design features such as deductibles, coinsurance, and copays. It allows users to quickly see the impact those benefit changes have on the plan’s actuarial value and overall cost relative to other plans.